NCT05130073Completed
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer
The Role of a 4-point Therapy Response Score With PET/CT Post Definitive Chemoradiation for Anal Squamous Cell Cancer: A Prospective Study
Source: ClinicalTrials.gov · Last updated 20 Feb 2024
Brief summary (registry, in English)
This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer respond to chemoradiation therapy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 41 (actual)
- First submitted
- 10 Nov 2021
- Start date
- 31 Jul 2019
- Primary completion date
- 14 Dec 2023
- Lead sponsor
- M.D. Anderson Cancer Center
- NCT number
- NCT05130073
What you commit to
- Study type: Observational
- Participants enrolled: 41
- From 31 Jul 2019 to the primary completion date, 14 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients unwilling to participate in a PET/CT at baseline and at 3 months post completion of definitive chemoradiation
Other illness
- Patients with an active second primary malignancy requiring chemotherapy or radiation treatment
Other
- Stage IV SCCA
Who the study is looking for
- Histologically confirmed biopsy proven invasive SCCA (any T, any N) deemed a candidate to undergo standard of care definitive chemoradiation at MD Anderson Cancer Center (MDACC) with curative intent
- Age \> 18 years at time of study entry
- Ability to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.